Stephanie Link Buys UnitedHealth Amidst Investor Interest and CEO Return

UnitedHealth's Recent Performance and Investor Confidence

• 💡 Berkshire Hathaway's revealed stake in UnitedHealth is seen as a significant indicator of value, alongside purchases by Appaloosa and Michael Bur.
• 📉 The stock has underperformed over the last six months, but investors like Stephanie Link believe value is present, especially with current trading multiples below historical averages.

Stephanie Link's Investment Rationale

• 🎯 Link highlights UnitedHealth's strong fundamentals, including 52 million members, significant size, and scale, despite recent stumbles and margin issues.
• 📈 The return of CEO Steve Hemsley, who previously led the company from 2006-2017 with a 346% stock rally, is a key factor, signaling confidence and a strategic direction.
• 💰 Hemsley's immediate purchase of 25 million shares upon his return is viewed as a strong vote of confidence.

Addressing Challenges and Future Outlook

• ⚠️ The company has faced challenges with utilization and needs to reprice its Medicare Advantage business, which is expected to improve performance.
• ⏳ This is considered a 2026 and 2027 story, requiring patience as the company works through current issues, with improvements not necessarily visible by year-end.
• 🛠️ Link believes the new CEO and management team will address the issues, with the current year's earnings being "kitchen-sinked" to set a new baseline.

Market Perspective and Valuation

• 📊 While Berkshire's stake is a small percentage of its portfolio, it's seen as a signal that the credibility problem for UNH may be ending.
• 🧐 Some investors, including notable value investors, are willing to accept volatility and risk, indicating a belief in the long-term opportunity despite the "show me" nature of the stock.
• 💰 The stock is trading at a discount to its peers and long-term average, presenting an opportunity for long-term investors willing to ride along with major investors.